Loading insider details...
Beta
Latest Form 4 (Oct 14, 2026): Exercise/Conversion of 22,583 NRIX shares, $42.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 14, 2026 | Nurix Therapeutics, Inc. (NRIX) | Exercise/Conversion | 22,583 | $42.0K |
| May 15, 2026 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 31,250 | n/a |
| May 1, 2026 | Biohaven Ltd. (BHVN) | Grant/Award | 68,693 | n/a |
| Sep 17, 2025 | Nurix Therapeutics, Inc. (NRIX) | Exercise/Conversion | 10,750 | $20.0K |
| May 19, 2025 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 25,000 | n/a |
| May 7, 2025 | Biohaven Ltd. (BHVN) | Grant/Award | 31,716 | n/a |
| May 20, 2024 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 25,000 | n/a |
| May 2, 2024 | Biohaven Ltd. (BHVN) | Grant/Award | 16,592 | n/a |
| May 4, 2023 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 25,000 | n/a |
| May 4, 2023 | Biohaven Ltd. (BHVN) | Grant/Award | 52,906 | n/a |